AIDriven Job Applications Risk Creating Homogeneous Candidate Pools Experts Suggest AnheuserBusch InBev Shares Dip as Quarterly Sales Fall Short of Analyst Expectations Sebi Chief Tuhin Kanta Pandey Backs Bond ETFs and Tokenisation as Corporate Debt Fundraising Nears Rs 9 Lakh Crore Survival Mode The Rise of the MultiJob Workforce Amid Rising Costs Leonardo Secures 320 Million Deal to Equip Kuwait Patrol Vessels Expanding Italys Gulf Presence Lenovo Shares Surge Over 15 on Record Earnings AI Revenue Nearly Doubles First Citizens BancShares Q1 2026 Earnings Earnings Surpass Estimates by Over 10 TISI Q1 2026 Earnings Widening Losses as Company Navigates Challenging Market Conditions MLKN Q1 2026 Earnings EPS Falls Short of Consensus Modestly Seabridge Gold Q1 2024 Earnings Net Loss per Share Reported Stock Edges Higher Arch Capital Group Ltd ACGLO Q1 2026 Earnings Slight EPS Miss Masks Resilient Underwriting Performance BHP Q1 2026 Earnings EPS Misses Estimates Amid Cost and Commodity Pressures Ondas Inc ONDS Surges 78 Bullish Momentum Testing Key Resistance Marathon Petroleum MPC Pushes Higher Testing Key Levels After 25 Gain FS Bancorp Inc FSBW Gains 157 as Stock Approaches Key Resistance Level Planet Green Holdings Corp PLAG Slips 3 as Stock Tests Key Support at 150 Beeline Holdings BLNE Edges Higher Testing Key Resistance Near 145 Cipla Stock Price Trends What Recent Movements Could Indicate for Investors PRIM Q1 2026 Earnings EPS Misses Estimates by 315 Amid Operational Headwinds Assurant Inc AIZ Navigates Slight Decline While Holding Key Support Levels Walmart Eyes Price Cuts With Tariff Refunds as Consumer Stress Rises Adagene Q2 2025 Earnings Clinical Progress Overshadows EPS Miss Shares Jump IONQ Q1 2026 Earnings EPS Beat Drives DoubleDigit Stock Surge Despite Revenue Disconnect WERN Q1 2026 Earnings Unexpected Profit Surprises to the Upside as Werner Beats Expectations PAGP Q1 2026 Earnings Stunning EPS Beat Drives Stock Higher DDS Q1 2026 Earnings EPS Misses Estimates Shares Rise on Resilient Performance XORTX Therapeutics Q1 2024 Earnings Steep EPS Miss Highlights PreRevenue Biotech Hurdles